The Insulin Resistance Craving Cycle: Why Hunger Comes Back Two Hours Later (2026)
Share
By Brandon, founder of Ozzi · Published August 23, 2026 · Updated October 31, 2026
You ate a real lunch. Two and a half hours later you're rummaging for something sweet and you can't explain why.
What is the insulin resistance craving cycle?
Insulin's job is to move glucose out of your blood and into cells. Insulin resistance means those cells have gotten less responsive to the signal, so the pancreas sends more insulin to get the same work done.
That extra insulin doesn't switch off cleanly. It keeps pulling glucose down past where it needed to stop.
Roughly 2 to 3 hours after a meal, blood glucose lands below where it started. Your brain reads that dip as a fuel problem and asks for food. Fast carbs fix the dip in minutes, which is exactly why you reach for them, and which is exactly what sets up the next one.
That's the cycle. Meal, spike, overshoot, dip, craving, repeat. If you've read our piece on hormonal hunger vs real hunger, this is the mechanical version of the same story.
Why do cravings hit 2 to 3 hours after eating?
The clearest human data on this comes from a 2021 study in Nature Metabolism. Researchers tracked 1,070 people wearing continuous glucose monitors across 8,624 standardized meals and 71,715 meals they chose themselves.
They compared three things against hunger: the glucose peak in the first 2 hours, the area under the glucose curve, and the dip at 2 to 3 hours.
The dip won. People with bigger dips reported more hunger at 2 to 3 hours, went a shorter time before their next meal, ate more at 3 to 4 hours, and ate more across the full 24 hours. The 24-hour correlation was the strongest of the set.
Worth being precise about what that study is and isn't. It's observational, in healthy adults, and the correlations are modest (r values from 0.14 to 0.27). It shows a real, repeatable pattern across a large group. It doesn't prove the dip causes the eating.
The loop, drawn out. The dip at stage 3 is the part that predicted hunger in the 1,070-person cohort.
Does insulin resistance change how your brain sees food?
In a 2019 study in the American Journal of Clinical Nutrition, researchers scanned 39 adults who were overweight or obese and had impaired fasting glucose, impaired glucose tolerance, or both.
Higher insulin resistance (measured by HOMA-IR) tracked with stronger activation in the nucleus accumbens, both sides of the insula, and the right cingulate gyrus when food images appeared. Those are reward and salience regions. Emotional eating scores tracked the same direction. Habitual leisure-time physical activity tracked the opposite way.
Note the population there. These were adults already sitting in the pre-diabetes range, recruited into a clinical study. It's a small sample and it's cross-sectional, so it can't tell you which came first. We wrote more about that population in pre-diabetes and GLP-1.
What has the research actually studied?
The research behind the insulin resistance cravings cycle ranges from an observational study of 1,070 healthy adults, in which a glucose dip at 2 to 3 hours predicted hunger and next-meal intake, to small brain-imaging and crossover studies and two reviews. Several of these studies enrolled participants who were under medical care or already had a metabolic diagnosis.
| Finding | Evidence type | Who was studied |
|---|---|---|
| Glucose dip at 2-3h predicts hunger and next-meal intake | Human, observational, n=1,070 | Healthy adults, UK and US cohorts |
| Insulin resistance tracks with food-cue brain activation | Human, cross-sectional fMRI, n=39 | Overweight adults with impaired glucose regulation |
| Insulin acts on midbrain reward circuitry | Human, randomized, intranasal insulin | Adults, small crossover sample |
| Brain insulin resistance as a treatable target | Review; long-term trials were negative | Mixed, includes clinical populations |
| Exercise improves brain insulin sensitivity | Review of animal and human work | Mixed |
Nothing in that table is a cure for anything.
How do you know if this is what's happening to you?
There's no self-test that diagnoses insulin resistance. That's a conversation with your doctor and a blood panel. But the pattern has a shape, and people recognize it fast.
Signs that fit the cycle:
- Hunger returns 2 to 3 hours after a full meal, reliably.
- The craving is specific and sweet, not general.
- You get shaky, foggy, or irritable before you get hungry.
- Eating something sweet fixes it within 10 minutes.
- Evenings are worse than mornings.
If the food thoughts run all day and not just at the dips, that's a different (and overlapping) thing. We covered it in what is food noise.
Why does this get louder in your late 30s and 40s?
The insulin resistance craving cycle gets louder in your late 30s and 40s because two things move at once, and in the same direction: you lose muscle from the mid-30s unless you defend it, and estrogen turns erratic through perimenopause.
We wrote it up in detail in perimenopause and insulin resistance.
PCOS runs a version of this earlier in life, and often more sharply. That's covered in PCOS cravings and insulin resistance.
What actually breaks the cycle?
The lever you control is the shape of the curve. Flatten the rise and you shrink the overshoot, and the dip gets smaller.
Protein and fat first. Eating the protein and vegetable portion of a meal before the starch slows gastric emptying and blunts the peak. Free, works immediately.
Viscous fiber with the meal. Soluble fibers that gel in the stomach slow carbohydrate absorption. Glucomannan from konjac root is the most studied of these for satiety.
Walking after meals. Muscle contraction pulls glucose out of the blood without needing insulin. Ten minutes does measurable work.
Chromium. An essential trace mineral with a long-established role in insulin receptor signaling. We went through the evidence, including where it's thinner than the marketing suggests, in chromium for cravings and blood sugar.
Where does Ozzi fit in this?
Ozzi is a drink stick. It was built around this exact loop, so here's the honest version of what's in it and why.
8g allulose. A rare sugar that tastes sweet without raising blood glucose the way sucrose does. It's there so the sweet craving gets something to land on that doesn't start another spike. More on that in does allulose spike blood sugar.
500mg glucomannan. The viscous konjac fiber above. Its lane is stomach fullness and slower carbohydrate absorption.
500mg L-Lysine Butyrate (BIOMEnd). Butyrate is a postbiotic, and it's the primary fuel for the cells lining your colon. The link between butyrate and GLP-1-secreting L-cells comes from mouse and cell studies. Human confirmation is still pending, so we frame it as support for a normal process, not a promise.
300mcg chromium (as Metabolex). For insulin signaling support.
What Ozzi doesn't do: it doesn't treat insulin resistance, and it isn't a substitute for medical care if your labs say something. It supports blood sugar control and gives the 9pm cravings somewhere to go.
If this pattern showed up in your late 30s or 40s, read our perimenopause cravings page next.
Frequently asked questions
Does the glucose dip mean my blood sugar is low?
The glucose dip usually does not mean your blood sugar is clinically low. In the Nature Metabolism cohort, these were healthy people whose glucose dropped below their own baseline. The brain seems to respond to the drop itself, not to an absolute number.
Can Ozzi replace medication for insulin resistance?
No. It's a supplement that supports blood sugar control and appetite. If you've been prescribed something, keep taking it and talk to your doctor before changing anything.
About the author
Brandon is the founder of Ozzi. He started reading metabolic research because his own cravings owned him after dinner, and he kept reading because most of what he found online overstated what the studies said. He writes these posts himself and labels every mechanism by what species it was tested in.

Six actives, no stimulants
Ozzi Crave Crusher
Konjac fiber for physical fullness, 8g of allulose for the sweet craving, plus butyrate, chromium, ursolic acid and African mango. No caffeine and no stimulants, so there is no cutoff time on when you can drink it.
See what's in it →References
- Wyatt P, Berry SE, Finlayson G, et al. Postprandial glycaemic dips predict appetite and energy intake in healthy individuals. Nature Metabolism. 2021;3(4):523-529. https://doi.org/10.1038/s42255-021-00383-x
- Drummen M, Dorenbos E, Vreugdenhil ACE, et al. Insulin resistance, weight, and behavioral variables as determinants of brain reactivity to food cues. American Journal of Clinical Nutrition. 2019;109(2):315-321. https://doi.org/10.1093/ajcn/nqy252
- Hallschmid M. Intranasal insulin. Journal of Neuroendocrinology. 2021;33(4):e12934. https://doi.org/10.1111/jne.12934
- Kullmann S, Blum D, Jaghutriz BA, et al. Modulation of midbrain neurocircuitry by intranasal insulin. NeuroImage. 2019;194:120-127. https://doi.org/10.1016/j.neuroimage.2019.03.050
- Malin SK, Stewart NR, Ude AA, Alderman BL. Brain insulin resistance and cognitive function: influence of exercise. Journal of Applied Physiology. 2022;133(6):1368-1380. https://doi.org/10.1152/japplphysiol.00375.2022
- Chambers ES, Viardot A, Psichas A, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744-1754. https://doi.org/10.1136/gutjnl-2014-307913
- Kroemer NB, Krebs L, Kobiella A, et al. Resting-state functional connectivity of brain regions involved in cognitive control, motivation, and reward is enhanced in obese females. American Journal of Clinical Nutrition. 2014;100(2):524-534. https://doi.org/10.3945/ajcn.113.080671
- Freeman CR, Zehra A, Ramirez V, et al. Impact of sugar on the body, brain, and behavior. Frontiers in Bioscience (Landmark Edition). 2018;23(12):2255-2266. https://doi.org/10.2741/4704
Citations retrieved via PubMed. This article is for education only and isn't medical advice. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
